Improving the quality of substance dependency treatment with pharmacotherapy

Substance Use and Misuse

Volumn 35, Issue 12-14, 2000, Pages 2095-2125

  Boyarsky, B K ^a   McCance Katz, E F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

'Cocaine abuse'; 'Substance abuse' pharmacotherapy; Alcohol dependence; Dual diagnosis treatment; Opioid dependence

Indexed keywords

ACAMPROSATE; ALCOHOL; AMANTADINE; ANTIDEPRESSANT AGENT; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; BUPRENORPHINE; BUSPIRONE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLONIDINE; COCAINE; DIAZEPAM; DISULFIRAM; DOPAMINE RECEPTOR STIMULATING AGENT; LEVACETYLMETHADOL; LOFEXIDINE; LORAZEPAM; MAZINDOL; METHADONE; METHYLPHENIDATE; NALTREXONE; NICOTINE; OXAZEPAM; UNINDEXED DRUG; VALPROIC ACID; ZIDOVUDINE;

CLINICAL TRIAL; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG WITHDRAWAL; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; HYPOTENSION; LIVER TOXICITY; META ANALYSIS; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW;

EID: 0034528546     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.3109/10826080009148251     Document Type: Review

References (143)

1. Treatment of acute alcohol withdrawal syndrome with carbamazepine: A double-blind comparison with tiapride
2. Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans
3. Alternate-day dosing during buprenorphine treatment of opioid dependence
4. Practice guideline for the treatment of patients with substance use disorders: Alcohol, cocaine, opioids
5. Desipramine treatment of cocaine dependence in methadone-maintained patients
6. A controlled trial of fluoxetine in crack cocaine dependence
7. Clonidine versus chlordiazepoxide in the management of acute alcohol withdrawal syndrome
8. Buprenorphine: Dose-related blockade of opioid challenge effects in opioid-dependent humans
9. The neuropsychiatry of chronic cocaine abuse
10. Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users
11. Lofexidine in alcohol withdrawal states
12. Buspirone in the treatment of alcoholic patients
13. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram
14. Psychotherapy and pharmacotherapy for ambulatory cocaine abuses
15. Pharmacologic interventions for abusers of alcohol and cocaine: Disulfiram versus naltrexone
16. Fluoxetine reduces intravenous cocaine self-administration in the rat
17. Clonidine and naltrexone: A safe, effective and rapid treatment of abrupt withdrawal from methadone therapy
18. Buprenorphine as a pharmacotherapy for opiate addiction
19. Carbamazepine treatment for cocaine dependence
20. Double-blind comparison of desipramine and placebo for treatment of cocaine dependence
21. Mazindol treatment of cocaine abuse: A double-blind investigation
22. Drug therapy reviews: Management of the disulfiram-alcohol reaction
23. Nicotine chewing gum in smoking cessation: Efficiency, nicotine dependence, therapy duration, and clinical recommendations
24. Enhancement of smoking cessation using the antidepressant bupropion hydrochloride
25. Levo-Alpha Acetyl Methadol (LAAM)
26. Tobacco dependence and the nicotine patch: Clinical guidelines for effective use
27. The effectiveness of the nicotine patch for smoking cessation: A meta analysis
28. Development of a therapeutic vaccine for the treatment of cocaine addiction
29. Efficacy of a therapeutic cocaine vaccine in rodent models
30. Disulfiram treatment of alcoholism: A Veteran's Administration cooperative study
31. Tobacco smoking and alcohol and drug consumption in a large, young, healthy population
32. Haight-Ashbury Free Clinics' drug detoxification protocols, Part 2: Opioid blockade
33. Pharmacological treatment of alcohol dependence: A review of the evidence
34. Desipramine facilitation of initial cocaine abstinence
35. Pharmacological treatment of cocaine abuse
36. Methylphenidate treatment of cocaine abusers without attention deficit disorder: A negative report
37. Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction
38. Bromocriptine in cocaine withdrawal
39. Clonidine for opiate withdrawal
40. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy
41. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: 2 placebo-controlled, double-blind trials
42. Absence of acute cocaine interactions with the MAO-B inhibitor selegiline
43. The sensitizing effect of tetraethylthiuram disulfide (Antabuse) to ethyl alcohol
44. Carbamazepine for cocaine addiction?
45. Nicotine, negative affect, and depression
46. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
47. Bromocriptine for cocaine dependence
48. Physical dependence on nicotine gum: Effect of duration of use
49. Use of leukocyte aldehyde dehydrogenase activity to monitor inhibitory effect of disulfiram treatment in alcoholism
50. Higher levels of nicotine in arterial than in venous blood after cigarette smoking
51. Disulfiram therapy in patients abusing cocaine and alcohol
52. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid
53. Effect of nicotine spray on smoking cessation. A randomized, placebo-controlled, double-blind study
54. Non-nicotine pharmacotherapies for smoking cessation
55. Human pharmacology and abuse potential of the analgesic buprenorphine
56. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency
57. Absolute bioavailability of nicotine applied to different nasal regions
58. Buprenorphine treatment of opioid dependence: Clinical trial of daily versus alternate-day dosing
59. A controlled trial of buprenorphine for opioid dependence
60. Amantadine in the early treatment of cocaine dependence: A double-blind, placebo-controlled trial
61. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital
62. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal
63. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain
64. Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure
65. Buprenorphine vs. methadone maintenance for opioid dependence
66. Crossover trial of mazindol for cocaine dependence
67. An open trial of sertraline for cocaine abuse
68. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine
69. Treatment of cocaine abuse using buprenorphine
70. Strategies to improve compliance with narcotic antagonists
71. Carbamazepine treatment of cocaine dependence: A placebo-controlled trial
72. Buspirone treatment of anxious alcoholics
73. Randomized clinical trial of atenolol in patients with alcohol withdrawal
74. Rifampin induced methadone withdrawal
75. Naloxone challenge in smokers
76. The dopamine hypothesis of the reinforcing properties of cocaine
77. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine
78. Sodium valproate in the treatment of the alcohol withdrawal syndrome
79. Cigarette smoking, nicotine addiction, and its pharmacologic treatment
80. Methlyphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: A pilot study
81. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction
82. Buprenorphine
83. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal
84. Acamprosate in alcohol dependence: How does it Work?
85. Gender differences in psychiatric comorbidity among cocaine-using opiate addicts
86. Modulating effect of cocaine use on alcohol use
87. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal
88. [1231] β-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts
89. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients
90. Bupropion reduces cocaine abuse in methadone-maintained patients
91. Chronic disulfiram treatment effects on intranasal cocaine administration - Initial results
92. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone - A multiple-dose study
93. Disulfiram effects on acute cocaine administration
94. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262)
95. The effects of buprenorphine on self-administration of cocaine and heroin 'speedball' combinations and heroin alone by rhesus monkeys
96. Safety and efficacy of bupropion in combination with bromocriptine for treatment of cocaine dependence
97. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic
98. Primary care-based ambulatory opioid detoxification: The results of a clinical trial
99. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence
100. Naltrexone and coping skills therapy for alcohol dependence: A controlled study
101. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users
102. Transdermal nicotine: A review of its phamacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation
103. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts
104. Disulfiram treatment for cocaine dependence in methadone maintained opioid addicts
105. Cocaine kindling and psychosis
106. A case of buprenorphine abuse
107. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat
108. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure-activity study
109. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics
110. Valproate in anxiety and withdrawal syndromes
111. Advances in smoking cessation treatment
112. Relapse prevention by acamprosate
113. Buprenorphine: Dose related effects on cocaine and opiate use in cocaine-abusing opioid-dependent humans
114. Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial
115. Opposite modulation of cocaine-seeking behavior by D1 and D2-like dopamine receptor agonists
116. 5-HT and alcohol abuse
117. Diazepam loading: Simplified treatment of alcohol withdrawal
118. Effects of cocaine prior to and during bupropion maintenance in cocaine abusers
119. Mazindol treatment for cocaine dependence
120. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers
121. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users
122. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence
123. Treatment of comorbid generalized anxiety in a recently detoxified alcohol population with a selective serotonergic drug (buspirone)
124. Disulfiram therapy in patients abusing cocaine and alcohol
125. Clinical utility of rapid clonidine naltrexone detoxification for opioid abusers
126. Naltrexone in the treatment of alcohol dependence
127. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence
128. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
129. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification
130. Opioid withdrawal during risperidone treatment
131. Disulfiram treatment of alcoholism
132. Acamprosate (calciumacetylhomotaurinate) decrease postsynaptic potentials in the rat neocortex: Possible involvement of excitatory amino acid receptors
133. Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens